"The U.S. Food and Drug Administration today approved Bexsero, a vaccine to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.
Bexsero is the second vaccine approved"...
Typhim Consumer (continued)
Before receiving this vaccination, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use, especially of: "blood thinners" (e.g., warfarin), cancer chemotherapy, corticosteroids (e.g., prednisone, dexamethasone), drugs that weaken the immune system (e.g., cyclosporine, tacrolimus).
This document does not contain all possible interactions. Therefore, before using this product, tell your doctor or pharmacist of all the products you use. Keep a list of all your medications with you, and share the list with your doctor and pharmacist.
OVERDOSE: Overdose with this vaccine is highly unlikely. If overdose is suspected, contact a poison control center or emergency room immediately. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center.
NOTES: As with any vaccine, this vaccine may not fully protect everyone who receives it.
MISSED DOSE: Not applicable.
STORAGE: Not applicable. This vaccine is given in a doctor's office or clinic and will not be stored at home.
Information last revised March 2013. Copyright(c) 2013 First Databank, Inc.
Additional Typhim Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.